95 Greene St. in Jersey City — Courtesy: Thor Equities Group
By Joshua Burd
Thor Equities Group has inked its first deal at a repurposed life sciences building in Jersey City, securing an 11,000-square-foot lease with the state’s largest hospital network.
According to the landlord, RWJBarnabas Health and Jersey City Medical Center will operate a primary and urgent care center at 95 Greene St. The facility will have a separate entrance on York Street and benefit from a busy location in the city’s Paulus Hook neighborhood, drawing traffic to the eight-story, 350,000-square-foot property that Thor acquired last year.
“We are very pleased to welcome RWJ Barnanbas/JCMC to their new home at 95 Greene Street,” said Joe Sitt, chairman of Thor Equities Group. “We are proud of our work at this development and are committed to providing organizations with state-of-the-art spaces to practice medicine and advance life sciences. 95 Greene benefits from powerful building infrastructure and we look forward to welcoming additional tenants to this trophy asset.”
The New York-based firm acquired 95 Greene from SJP Properties, which had operated the building as high-end office space. The complex originally served as a manufacturing plant for Colgate-Palmolive, leaving it with robust utilities infrastructure and abundant power resources served by multiple utility grids, along with 13- to 15-foot ceiling heights, secured interior loading docks, an on-site life-safety generator and flexible floor plates.
Thor worked with SGA Architects to complete a sweeping adaptive reuse project for 95 Greene St., with base building work such as upgraded mechanicals, HVAC, vertical conduits and a new rooftop generator.
Thor kicks off construction to create new lab, R&D building in Jersey City, JLL says
